These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9124449)

  • 21. Losartan reduces monocyte chemoattractant protein-1 expression in aortic tissues of 2K1C hypertensive rats.
    Xie QY; Sun M; Yang TL; Sun ZL
    Int J Cardiol; 2006 Jun; 110(1):60-6. PubMed ID: 16242797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renin secretion in conscious Lyon hypertensive rats.
    Bertolino S; Julien C; Medeiros IA; Cuisinaud G; Vincent M; Barrès C
    Am J Physiol; 1996 Nov; 271(5 Pt 2):R1199-204. PubMed ID: 8945954
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure.
    Levy BI; Benessiano J; Henrion D; Caputo L; Heymes C; Duriez M; Poitevin P; Samuel JL
    J Clin Invest; 1996 Jul; 98(2):418-25. PubMed ID: 8755652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiotensin receptor blockade improves vascular compliance in healthy normotensive elderly individuals: results from a randomized double-blind placebo-controlled trial.
    Rajagopalan S; Kariisa M; Dellegrottaglie S; Bard RL; Kehrer C; Matlow S; Daley W; Pitt B; Brook R
    J Clin Hypertens (Greenwich); 2006 Nov; 8(11):783-90. PubMed ID: 17086018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Study of the visco-elastic response of the aortic wall to angiotensin and noradrenaline in the conscious dog by analysis of the instantaneous pressure-diameter relation in the descending aorta].
    Cabrera E; Levenson J; Armentano R; Barra JC; Pichel R; Simon A
    Arch Mal Coeur Vaiss; 1987 Jun; 80(6):789-93. PubMed ID: 3116973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Additional hypotensive effect of endothelin-1 receptor antagonism in hypertensive dogs under angiotensin-converting enzyme inhibition.
    Donckier JE; Massart PE; Hodeige D; Van Mechelen H; Clozel JP; Laloux O; Ketelslegers JM; Charlier AA; Heyndrickx GR
    Circulation; 1997 Aug; 96(4):1250-6. PubMed ID: 9286956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiotensin-converting enzyme and angiotensin II receptor subtype 1 inhibitors restitute hypertensive internal anal sphincter in the spontaneously hypertensive rats.
    De Godoy MA; Rattan S
    J Pharmacol Exp Ther; 2006 Aug; 318(2):725-34. PubMed ID: 16648368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antihypertensive advantages of angiotensin II AT1 receptor antagonism].
    Coca A; Giner V
    Rev Esp Cardiol; 1999; 52 Suppl 3():53-8. PubMed ID: 10614150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Converting enzyme inhibition modulates sympathetic neurotransmission in vivo via multiple mechanisms.
    Schwieler JH; Kahan T; Nussberger J; Hjemdahl P
    Am J Physiol; 1993 Apr; 264(4 Pt 1):E631-7. PubMed ID: 8386457
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of SC-52458, an angiotensin AT1 receptor antagonist, in the dog.
    McMahon EG; Yang PC; Babler MA; Suleymanov OD; Palomo MA; Olins GM; Cook CS
    Am J Hypertens; 1997 Jun; 10(6):671-7. PubMed ID: 9194514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vascular changes in hypertension in response to drug treatment: Effects of angiotensin receptor blockers.
    Schiffrin EL
    Can J Cardiol; 2002 May; 18 Suppl A():15A-18A. PubMed ID: 12045789
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass.
    Lafayette RA; Mayer G; Park SK; Meyer TW
    J Clin Invest; 1992 Sep; 90(3):766-71. PubMed ID: 1522231
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Load-sensitive diastolic relaxation in hypertrophied left ventricles.
    Hayashida W; Donckier J; Van Mechelen H; Charlier AA; Pouleur H
    Am J Physiol; 1998 Feb; 274(2):H609-15. PubMed ID: 9486265
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autonomic function and baroreflex sensitivity during angiotensin-converting enzyme inhibition or angiotensin II AT-1 receptor blockade in essential hypertensive patients.
    Guasti L; Petrozzino MR; Mainardi LT; Grimoldi P; Zanotta D; Garganico D; Diolisi A; Simoni C; Grandi AM; Gaudio G; Cerutti S; Venco A
    Acta Cardiol; 2001 Oct; 56(5):289-95. PubMed ID: 11712824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative study of effects of angiotensin II receptor antagonist, KD3-671, and angiotensin converting enzyme inhibitor, enalaprilat, on cough reflex in guinea pig.
    Miyamoto H; Ito K; Ito K; Wakabayashi S; Suzaka H; Matsuo H; Iga T; Sawada Y
    Eur J Drug Metab Pharmacokinet; 2001; 26(1-2):47-52. PubMed ID: 11554433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiotensin II receptor subtypes in renal cortex of rats and rhesus monkeys.
    Gibson RE; Thorpe HH; Cartwright ME; Frank JD; Schorn TW; Bunting PB; Siegl PK
    Am J Physiol; 1991 Sep; 261(3 Pt 2):F512-8. PubMed ID: 1653532
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maintenance of blood pressure in normotensive dogs by endothelin.
    Münter K; Ehmke H; Kirchengast M
    Am J Physiol; 1999 Mar; 276(3):H1022-7. PubMed ID: 10070087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of chronic inhibition of converting enzyme on mechanical and structural properties of arteries in rat renovascular hypertension.
    Levy BI; Michel JB; Salzmann JL; Azizi M; Poitevin P; Safar M; Camilleri JP
    Circ Res; 1988 Jul; 63(1):227-39. PubMed ID: 3383377
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiotensin II and endothelin-1 receptor antagonists have cumulative hypotensive effects in canine Page hypertension.
    Massart PE; Hodeige DG; Van Mechelen H; Charlier AA; Ketelslegers JM; Heyndrickx GR; Donckier JE
    J Hypertens; 1998 Jun; 16(6):835-41. PubMed ID: 9663924
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of Angiotensin Converting Enzyme, Angiotensin II Receptor Blocking, and Blood Pressure Lowering Bioactivity across Plant Families.
    Patten GS; Abeywardena MY; Bennett LE
    Crit Rev Food Sci Nutr; 2016; 56(2):181-214. PubMed ID: 24915402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.